Pictured: Douglas Levine
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Wednesday, May 1, 2013

An analysis of endometrial cancers reveals genetic information that should improve diagnosis and guide treatments for women with an aggressive form of the disease.

Pictured: Charles Sawyers
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, April 30, 2013

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Pictured: ESK1 Monoclonal Antibody
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, March 13, 2013

Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Pictured: Neurons
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Monday, February 11, 2013

Researchers have clarified the process by which developing nerve cells are directed to specialize into distinct parts.

Pictured: BCG
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Friday, February 1, 2013

Researchers have shed light on how an important treatment for early-stage bladder cancer enters cancer cells to eradicate them.

Pictured: Prasad Adusumilli
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, January 3, 2013

A team from Memorial Sloan Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.

Pictured: X-ray Image
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, December 19, 2012

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.

Pictured: Michel Sadelain
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, December 18, 2012

Memorial Sloan Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Pictured: Ming Li
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, December 14, 2012

Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.

Pictured: PET Scan
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, November 15, 2012

Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.

Pictured: Marc Ladanyi & Snjezana Dogan
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Friday, November 9, 2012

A genetic analysis of tumors suggests women are more susceptible than men to the most common form of lung cancer.

Pictured: Structure of Synthesized Erythropoietin
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, October 8, 2012

Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.

Pictured: Tunneling Nanotubes
Snapshot
By Memorial Sloan Kettering  |  Wednesday, September 19, 2012

Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.

In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, September 17, 2012

When new cancer drugs are shown to be largely ineffective, exceptional cases of good outcome may pave the way for new treatments that could benefit a smaller group of patients.

Pictured: Ross Levine
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Thursday, September 6, 2012

Memorial Sloan Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms.

Center News

Stay Informed

Get the latest information about cancer care and research every month.